Global Healthcare|23 Apr 2020

Blue Chip Healthcare; Leading from the front

James Douglas

Fund Manager, Global Healthcare Team

Demand for healthcare products and services from blue chip companies not only continues but is accelerating in some cases. At the same time, valuations look attractive and we have only just begun to see a change in sector leadership. Listen to James Douglas discuss why blue chip healthcare companies are leading from the front.

Download transcript

James Douglas, PhD
James joined Polar Capital in September 2015 and is a Fund Manager for the Healthcare team. He was appointed Co-Fund Manager for the Polar Capital Global Healthcare Trust in May 2017.
Prior to joining Polar Capital, James worked in equity sales specialising in global healthcare at Morgan Stanley, RBS and HSBC. James also has equity research experience garnered from his time at UBS, where he worked as an analyst in the European pharmaceutical and biotechnology team. Before moving across to the financial sector, he worked as a consultant for EvaluatePharma.